Mentor Awaits Breast Implant Approval; Advocacy Groups Fight To Stop FDA
This article was originally published in The Gray Sheet
Executive Summary
Mentor acknowledges that saline breast implant sales could slow in anticipation of silicone breast implant approval imminently
You may also be interested in...
Mentor’s Stock Jumps In Q3 On Silicone Implant “Approvable” Letter
FDA's "approvable" letter to Mentor for the Memory Gel silicone breast implants drove the firm's stock up 32.6% to $55.01 for the quarter, but investor tunnel-vision could keep future stock movement tied to FDA's final decision
Mentor’s Stock Jumps In Q3 On Silicone Implant “Approvable” Letter
FDA's "approvable" letter to Mentor for the Memory Gel silicone breast implants drove the firm's stock up 32.6% to $55.01 for the quarter, but investor tunnel-vision could keep future stock movement tied to FDA's final decision
Execs Should Monitor Advocacy Group Concerns, Media Coverage – Diermeier
Medical device executives should stay abreast of advocacy group concerns and media portrayal in order to effectively manage the image of their products, according to Daniel Diermeier, PhD, Northwestern University